The U.S. virtual care market size was USD 2.26 billion in 2023, calculated at USD 2.99 billion in 2024 and is projected to surpass around USD 49.68 billion by 2034, expanding at a CAGR of 32.5% from 2024 to 2034.
The U.S. virtual care market size accounted for USD 2.99 billion in 2024 and is expected to be worth around USD 49.68 billion by 2034, at a CAGR of 32.5% from 2024 to 2034.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
Virtual care is a method of treating patients with everyday health problems using video, audio, or written communication. This is also called a virtual visit using a communication device that both the patient and the doctor hold at different locations. Virtual care methods are mainly used for meetings, routine health consultations, etc. Virtual visits consist of “virtual visits” conducted between a patient and a healthcare provider using telecommunication technology. The term “virtual” refers to the real-time virtual meeting of patients and physicians from anywhere.
| Report Coverage | Details |
| Market Size in 2023 | USD 2.26 Billion |
| Market Size in 2024 | USD 2.99 Billion |
| Market Size by 2034 | USD 49.68 Billion |
| Growth Rate from 2024 to 2034 | CAGR of 32.5% |
| Base Year | 2024 |
| Forecast Period | 2024 to 2034 |
| Segments Covered | Service Type, Technology Type, and End-user |
Increasing prevalence of chronic diseases
The growing elderly population in the United States is creating a highly favourable environment for chronic diseases. For instance, the CDC stated that chronic diseases like cardiovascular diseases, cancer, diabetes, and respiratory diseases increase approximately 70% of deaths every year in the united states. Moreover, the WHO report also found that the global population aged 60 and over will double from 12% to 22% between 2015 and 2022.
A growing number of smartphone users
The smartphone users are increasing continuously as the availability of the internet. The total smartphone users in Unite State are 298 million. The smartphone is the easiest way for using and connecting virtually. The US smartphone market is one of the largest in the world with approximately 298 million smartphone users (as of 2021). In line with the overall growth of the global smartphone market, US smartphone penetration has increased steadily in recent years, reaching 85% in February 2021.
Security concerns might restrict the US virtual care market progression
Security concerns related to sensitive patient data may limit its value to the industry. Telemedicine solutions require platform integration for electronic prescriptions, electronic patient files, and medical or fitness apps, among others. Data breaches can lead to unauthorized access to sensitive information such as medical records, medical records, prescriptions, insurance cards, personal ID cards, social security numbers, and addresses. Data breaches therefore negatively affect the overall reputation of telemedicine providers.
Rising demand for tele-consulting to showcase significant market growth
The rapid change in the acceptance of virtual consultations has improved access to medical services, even in remote areas. It was also observed that the user adoption rate jumped from 11% to 46% within one year. Additionally, telemedicine maximizes patient reach at minimal cost, making it cost-effective. The need for remote patient monitoring is driving increased demand for tele-hospital services. The growing need to provide efficient, high-quality healthcare services at affordable prices is also a major contributor to industry sales. In addition, growing public awareness of the-hospital services such as daytime patient visits, emergency room visits, night-time calls and hospitalizations is projected to increase industry demand for telemedicine. 84 percent of physicians were offering virtual visits and 57 per cent would prefer to continue offering virtual care.
The telemedicine segment dominated the U.S. virtual care market in 2023 due to the increased emphasis on remote consultation. Telemedicine is increasingly used due to its ability to provide remote consultations and treatment, reducing frequent hospital visits. It allows patients to connect with physicians through video calls, thereby enhancing convenience and overall patient outcomes. Advancements in technology, such as electronic health records and remote monitoring devices, have improved the effectiveness and capabilities of telemedicine. Moreover, the rising policies in the U.S. that facilitate telemedicine reimbursement contributed to the segment growth.
The video conferencing technology segment held a large share of the market in 2023. Video conferencing platforms, including Zoom and Microsoft Teams, have become essential in delivering virtual care services. These platforms have become essential for conducting virtual appointments and consultations, enabling continuity of care during challenging times. The COVID-19 pandemic has further boosted the adoption of remote healthcare solutions. The increasing demand for personalized care further augmented the segment.
The patients segment dominated the U.S. virtual care market in 2023. The increasing adoption of wearable devices, remote monitoring devices, and mobile health apps among patients to reduce healthcare costs and enhance health outcomes contributed to the segment expansion. The growing prevalence of chronic diseases in the U.S. further encouraged patients to use remote patient monitoring and remote consultation services, as some chronic diseases require regular checkups to manage symptoms. Moreover, the increasing adoption of mHealth apps among patients contributed to the segmental growth.
Segments Covered in the Report
By Service Type
By Technology Type
By End-user
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on US Virtual Care Market
5.1. COVID-19 Landscape: US Virtual Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. US Virtual Care Market, By Application
8.1. US Virtual Care Market, by Application, 2024-2034
8.1.1. Family Medicine
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Internal Medicine
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Cardiology
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Paediatrics
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Endocrinology
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Rheumatology
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Pulmonology
8.1.7.1. Market Revenue and Forecast (2021-2034)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2021-2034)
Chapter 9. US Virtual Care Market, By Consultation Mode
9.1. US Virtual Care Market, by Consultation Mode, 2024-2034
9.1.1. Audio
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Video
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Messaging
9.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 10. US Virtual Care Market, Regional Estimates and Trend Forecast
10.1. US
10.1.1. Market Revenue and Forecast, by Application (2021-2034)
10.1.2. Market Revenue and Forecast, by Consultation Mode (2021-2034)
Chapter 11. Company Profiles
11.1. AMD Global Telemedicine
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. CHI Health
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. ATandT
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Koninklijke Philips N.V.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. GENERAL ELECTRIC COMPANY
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cerner Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. MDLIVE Inc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Siemens Healthcare GmbH
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. United HealthCare Services, Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. American Well
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample